Guerbet's innovation, Eluciremâ„¢ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...
Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
One of the most underserved areas in our states is pediatrics. And we knew that. And we needed guidance from experts. But we had connections. We do a lot of rural work, we know the communities. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results